NEPA as an Effective Therapeutic Approach for Managing ADC-Induced Nausea and Vomiting

20 Aug 2024Oncology

Jessica LAU

This content is sponsored. It is intended for healthcare professionals only.

Nausea and vomiting are common adverse effects associated with antibody-drug conjugates (ADCs), significantly impacting patients’ quality of life (QoL) and treatment adherence.

NEPA as an Effective Therapeutic Approach for Managing ADC-Induced Nausea and Vomiting 2024

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.